EXAS
NASDAQ · Biotechnology
Exact Sciences Corp
$104.91
+0.99 (+0.95%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+97.50%
YTD
+3.12%
Open$104.93
Previous Close$103.92
Day High$104.98
Day Low$104.90
52W High$104.98
52W Low$51.75
Volume—
Avg Volume4.06M
Market Cap20.03B
P/E Ratio—
EPS$-1.10
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$102.19
Above
SMA 200
$69.24
Above
RSI (14)
74.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
29 analysts
Price Target
+24.6% upside
Current
$104.91
$104.91
Target
$130.71
$130.71
$80.73
$130.71 avg
$205.54
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.28B | 2.83B | 5.75B |
| Net Income | -210,377,895 | -163,336,875 | -895,146,132 |
| Profit Margin | -6.4% | -6.1% | -15.6% |
| EBITDA | -82,368,262 | -67,503,320 | -1,423,315,581 |
| Free Cash Flow | — | — | -873,819,141 |
| Rev Growth | +15.9% | +15.9% | -4.7% |
| Debt/Equity | 0.97 | 0.97 | 0.09 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.97 | -0.04% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $405.71 | -0.09% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.81 | -0.37% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $522.63 | +1.22% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $797.37 | -0.56% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $248.51 | +0.81% | 40.0 | 32.33B |